Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05204927
Title Lu-177-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Curium US LLC
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Enzalutamide

lutetium Lu 177 vipivotide tetraxetan

Abiraterone + Prednisone

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.